EKF Diagnostics Holdings ( (GB:EKF) ) just unveiled an update.
EKF Diagnostics Holdings plc has announced the buyback of 278,000 of its ordinary shares at a weighted average price of 22.5 pence per share, which will be held in treasury. This move impacts the company’s total voting rights, now consisting of 452,610,871 shares, and is part of a strategy to maintain shareholder interests, particularly that of Mr. Mills, whose indirect beneficial interest remains stable. The buyback reflects EKF’s ongoing efforts to manage its capital structure and maintain its market position.
More about EKF Diagnostics Holdings
EKF Diagnostics Holdings plc is an AIM-listed global diagnostics business specializing in point-of-care analyzers for hematology and diabetes, as well as life sciences services that provide specialist manufacture of enzymes and custom products for diagnostic, food, and industrial applications. The company is headquartered in Penarth, near Cardiff, and operates five manufacturing sites across the US and Germany, selling products in over 120 countries worldwide.
YTD Price Performance: -20.37%
Average Trading Volume: 546,251
Technical Sentiment Signal: Strong Buy
Current Market Cap: £97.37M
See more insights into EKF stock on TipRanks’ Stock Analysis page.